Robinson Triboulet began their career in 2004 as a Graduate Student at the Institut de Génétique Humaine. In 2008, they moved to the Boston Children's Hospital as a Research Fellow. In 2018, they joined Redona Therapeutics (formerly Twentyeight-Seven) as a Senior Scientist and later a Scientist.
Robinson Triboulet received a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from the University of Montpellier between 2004 and 2007. Prior to that, they earned a Master of Science (M.S.) in Biology & Health from the same university between 2004 and 2005.
September, 2021 - present
November, 2018